Sai Parenterals working capital

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	FY26Mar 2026

	258.90×
	173.43×
	223.94×
	208.39×
	1.53×
	0.27×
	6.53×
	2.40×

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

SAIPARENT₹505.70

Sai Parenterals Limited

· Pharma & Health

₹ CrorePeersINDOCO PANACEABIO HIKAL WINDLAS HESTERBIO DCAL SYNCOMF SOLARAMcap ₹2,234 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

	Ratios — % unless marked × 12 Months Ending	FY26 31/03/2026
	Inventory Days (DIO)	258.90
	Receivable Days (DSO)	173.43
	Payable Days (DPO)	223.94
	Cash Conversion Cycle (days)	208.39
	Working Capital Turnover	1.53
	Asset Turnover	0.27
	Cash Conversion (CFO/Net Income)	6.53
	CFO/EBITDA	2.40

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.